A new trading day began on Monday, with Alx Oncology Holdings Inc (NASDAQ: ALXO) stock price down -5.43% from the previous day of trading, before settling in for the closing price of $1.29. ALXO’s price has ranged from $1.25 to $17.83 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -8.67% over the past five years. Meanwhile, its annual earnings per share averaged 25.36%. With a float of $26.24 million, this company’s outstanding shares have now reached $49.95 million.
Let’s look at the performance matrix of the company that is accounted for 72 employees. In terms of profitability, gross margin is 74.15%, operating margin of -6446.65%, and the pretax margin is -6095.12%.
Alx Oncology Holdings Inc (ALXO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Alx Oncology Holdings Inc is 50.26%, while institutional ownership is 58.47%. The most recent insider transaction that took place on Aug 14 ’24, was worth 1,455. In this transaction SVP, FINANCE AND CAO of this company sold 564 shares at a rate of $2.58, taking the stock ownership to the 91,549 shares. Before that another transaction happened on Aug 14 ’24, when Company’s CHIEF MEDICAL OFFICER sold 1,365 for $2.58, making the entire transaction worth $3,522. This insider now owns 325,711 shares in total.
Alx Oncology Holdings Inc (ALXO) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 25.36% per share during the next fiscal year.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
Here are Alx Oncology Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.98, a number that is poised to hit -0.68 in the next quarter and is forecasted to reach -2.50 in one year’s time.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
Alx Oncology Holdings Inc (NASDAQ: ALXO) saw its 5-day average volume 1.13 million, a positive change from its year-to-date volume of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 7.79%. Additionally, its Average True Range was 0.12.
During the past 100 days, Alx Oncology Holdings Inc’s (ALXO) raw stochastic average was set at 0.13%, which indicates a significant decrease from 2.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.11% in the past 14 days, which was lower than the 117.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6729, while its 200-day Moving Average is $7.9906. Nevertheless, the first resistance level for the watch stands at $1.2767 in the near term. At $1.3333, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.3667. If the price goes on to break the first support level at $1.1867, it is likely to go to the next support level at $1.1533. The third support level lies at $1.0967 if the price breaches the second support level.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Key Stats
With a market capitalization of 62.41 million, the company has a total of 52,743K Shares Outstanding. Currently, annual sales are 0 K while annual income is -160,810 K. The company’s previous quarter sales were 0 K while its latest quarter income was -30,710 K.
